American Journal of Clinical Nutrition, Vol 42, 644-649, Copyright © 1985 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes

CW Lo, PW Paris, TL Clemens, J Nolan and MF Holick

We developed a test procedure for the clinical evaluation of the absorption of vitamin D. Serum vitamin D concentrations were evaluated in seven patients with intestinal fat malabsorption syndromes and in seven healthy, normal subjects, after being given a single oral dose of 50,000 IU (1.25 mg) vitamin D2. In the normal subjects, serum vitamin D concentrations rose from a baseline of less than 5 ng/ml to a peak of over 50 ng/ml by 12 h, gradually falling to baseline levels by 3 days. In five of the seven patients with intestinal fat malabsorption, oral administration of 50,000 IU vitamin D2 did not raise serum vitamin D concentrations above 10 ng/ml. Two patients with severe inflammatory bowel disease had a normal absorption pattern, however. These findings suggest that an oral vitamin D absorption test may be of value for determination of patients at risk for development of vitamin D deficiency. They also raise questions about the efficacy of oral vitamin D preparations in patients with intestinal fat malabsorption.

This article has been cited by other articles:

				M. F. Holick Vitamin D Deficiency N. Engl. J. Med., July 19, 2007; 357(3): 266 - 281. [Full Text] [PDF]

				G. Schwalfenberg Not enough vitamin D: Health consequences for Canadians Can Fam Physician, May 1, 2007; 53(5): 841 - 854. [Abstract] [Full Text] [PDF]

				H. M. Pappa, C. M. Gordon, T. M. Saslowsky, A. Zholudev, B. Horr, M.-C. Shih, and R. J. Grand Vitamin D Status in Children and Young Adults With Inflammatory Bowel Disease Pediatrics, November 1, 2006; 118(5): 1950 - 1961. [Abstract] [Full Text] [PDF]

				M. F. Holick The Vitamin D Epidemic and its Health Consequences J. Nutr., November 1, 2005; 135(11): 2739S - 2748S. [Abstract] [Full Text] [PDF]

				M. F Holick and V. Tangpricha Reply to MA Weinstock and D Lazovich Am. J. Clinical Nutrition, September 1, 2005; 82(3): 707 - 708. [Full Text] [PDF]

				M. P. Boyle, M. L. Noschese, S. L. Watts, M. E. Davis, S. E. Stenner, and N. Lechtzin Failure of High-Dose Ergocalciferol to Correct Vitamin D Deficiency in Adults with Cystic Fibrosis Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 212 - 217. [Abstract] [Full Text] [PDF]

				K V Haderslev, P B Jeppesen, H A Sorensen, P B Mortensen, and M Staun Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection Gut, May 1, 2003; 52(5): 653 - 658. [Abstract] [Full Text]

				T. A Sentongo, E. J Semaeo, N. Stettler, D. A Piccoli, V. A Stallings, and B. S Zemel Vitamin D status in children, adolescents, and young adults with Crohn disease Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1077 - 1081. [Abstract] [Full Text] [PDF]

				S. S. Harris and B. Dawson-Hughes Plasma Vitamin D and 25OHD Responses of Young and Old Men to Supplementation with Vitamin D3 J. Am. Coll. Nutr., August 1, 2002; 21(4): 357 - 362. [Abstract] [Full Text] [PDF]

				J. Wortsman, L. Y Matsuoka, T. C Chen, Z. Lu, and M. F Holick Decreased bioavailability of vitamin D in obesity Am. J. Clinical Nutrition, September 1, 2000; 72(3): 690 - 693. [Abstract] [Full Text] [PDF]

				K V Haderslev, P B Jeppesen, P B Mortensen, and M Staun Absorption of calcium and magnesium in patients with intestinal resections treated with medium chain fatty acids Gut, June 1, 2000; 46(6): 819 - 823. [Abstract] [Full Text] [PDF]